Literature DB >> 31838618

Successful Treatment of Long Standing Complex Regional Pain Syndrome with Hyperbaric Oxygen Therapy.

Karen Binkley1, Rita Katznelson2.   

Abstract

Complex regional pain syndrome (CRPS) is a devastating posttraumatic neuroinflammatory condition with both autoinflammatory and autoimmune features, characterized by unrelenting severe pain and disability, with the majority of affected patients being unable to function socially or vocationally. Remission is more likely in children than adults, and if treatment is started early. Once established, there are no universally effective treatments, and these are desperately needed. A single limb is often involved, but there can be multi-limb spread, and systemic autonomic manifestations. We describe a case of long-standing CRPS with multi-limb spread and systemic autonomic features, controlled only with very high dose oral corticosteroids, which led to several complications. Multiple other treatment modalities failed or were insufficient to control the CRPS and allow tapering of the corticosteroids, but the patient had a dramatic response to hyperbaric oxygen therapy (HBOT), allowing a reduction in prednisone dose to just over the physiologic range. When symptoms started to increase several months later, a second course of HBOT treatments allowed reduction in prednisone dose into the physiologic range while still controlling CRPS symptoms. This case is unique in that it shows that HBOT can be effective in long-standing CRPS, both initially, and for subsequent flares, and adds to the evidence supporting HBOT as a potential treatment for this condition. Graphical Abstract HBOT effect on prednisone dose for symptom control.

Entities:  

Keywords:  Complex regional pain syndrome; Hyperbaric oxygen

Mesh:

Year:  2019        PMID: 31838618     DOI: 10.1007/s11481-019-09901-x

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  30 in total

1.  Short-Term Glucocorticoid Treatment Normalizes the Microcirculatory Response to Remote Ischemic Conditioning in Early Complex Regional Pain Syndrome.

Authors:  Nina Kumowski; Tobias Hegelmaier; Jonas Kolbenschlag; Tina Mainka; Beate Michel-Lauter; Christoph Maier
Journal:  Pain Pract       Date:  2018-11-05       Impact factor: 3.183

2.  Investigate the Effect of Psychological Factors in Development of Complex Regional Pain Syndrome Type I in Patients with Fracture of the Distal Radius: A Prospective Study.

Authors:  Maryam Farzad; Fereydoun Layeghi; Ali Hosseini; Al Dianat; Nadiyeh Ahrari; Mehdi Rassafiani; Hooshang Mirzaei
Journal:  J Hand Surg Asian Pac Vol       Date:  2018-12

Review 3.  Movement disorders in complex regional pain syndrome.

Authors:  Jacobus J van Hilten
Journal:  Pain Med       Date:  2010-08       Impact factor: 3.750

4.  Effects of hyperbaric oxygen therapy on NACHT domain-leucine-rich-repeat- and pyrin domain-containing protein 3 inflammasome expression in rats following spinal cord injury.

Authors:  Fang Liang; Chunsheng Li; Chunjin Gao; Zhuo Li; Jing Yang; Xuehua Liu; Yong Wang
Journal:  Mol Med Rep       Date:  2015-02-06       Impact factor: 2.952

5.  Objective sensory evaluation of the spread of complex regional pain syndrome.

Authors:  Lara Edinger; Robert J Schwartzman; Ayesha Ahmad; Kirsten Erwin; Guillermo M Alexander
Journal:  Pain Physician       Date:  2013 Nov-Dec       Impact factor: 4.965

6.  Plasma Exchange Therapy in Patients with Complex Regional Pain Syndrome.

Authors:  Enrique Aradillas; Robert J Schwartzman; John R Grothusen; Andreas Goebel; Guillermo M Alexander
Journal:  Pain Physician       Date:  2015 Jul-Aug       Impact factor: 4.965

7.  Effectiveness of hyperbaric oxygen therapy in the treatment of complex regional pain syndrome.

Authors:  M Z Kiralp; S Yildiz; D Vural; I Keskin; H Ay; H Dursun
Journal:  J Int Med Res       Date:  2004 May-Jun       Impact factor: 1.671

8.  Report of a preliminary discontinued double-blind, randomized, placebo-controlled trial of the anti-TNF-α chimeric monoclonal antibody infliximab in complex regional pain syndrome.

Authors:  Maaike Dirckx; George Groeneweg; Feikje Wesseldijk; Dirk L Stronks; Frank J P M Huygen
Journal:  Pain Pract       Date:  2013-05-22       Impact factor: 3.183

9.  Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1-induced mechanisms.

Authors:  Zsuzsanna Helyes; Valéria Tékus; Nikolett Szentes; Krisztina Pohóczky; Bálint Botz; Tamás Kiss; Ágnes Kemény; Zsuzsanna Környei; Krisztina Tóth; Nikolett Lénárt; Hajnalka Ábrahám; Emmanuel Pinteaux; Sheila Francis; Serena Sensi; Ádám Dénes; Andreas Goebel
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-10       Impact factor: 11.205

10.  [11C]-(R)-PK11195 positron emission tomography in patients with complex regional pain syndrome: A pilot study.

Authors:  So Yeon Jeon; Seongho Seo; Jae Sung Lee; Soo-Hee Choi; Do-Hyeong Lee; Ye-Ha Jung; Man-Kyu Song; Kyung-Jun Lee; Yong Chul Kim; Hyun Woo Kwon; Hyung-Jun Im; Dong Soo Lee; Gi Jeong Cheon; Do-Hyung Kang
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

View more
  1 in total

Review 1.  Mechanistic Rationale and Clinical Efficacy of Hyperbaric Oxygen Therapy in Chronic Neuropathic Pain: An Evidence-Based Narrative Review.

Authors:  Simone Schiavo; Julian DeBacker; Carine Djaiani; Anuj Bhatia; Marina Englesakis; Rita Katznelson
Journal:  Pain Res Manag       Date:  2021-04-22       Impact factor: 3.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.